Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

PURPOSE: Patients with advanced endometrial carcinoma have limited treatment options. We report final primary efficacy analysis results for a patient cohort with advanced endometrial carcinoma receiving lenvatinib plus pembrolizumab in an ongoing phase Ib/II study of selected solid tumors. METHODS:...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Oncol
Main Authors: Makker, Vicky, Taylor, Matthew H., Aghajanian, Carol, Oaknin, Ana, Mier, James, Cohn, Allen L., Romeo, Margarita, Bratos, Raquel, Brose, Marcia S., DiSimone, Christopher, Messing, Mark, Stepan, Daniel E., Dutcus, Corina E., Wu, Jane, Schmidt, Emmett V., Orlowski, Robert, Sachdev, Pallavi, Shumaker, Robert, Casado Herraez, Antonio
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2020
Subjects:
ORIGINAL REPORTS
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479759/
https://ncbi.nlm.nih.gov/pubmed/32167863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.02627
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items